A case report of angioedema during long-term (66 months) angiotensin converting enzyme inhibition therapy with enalapril

Japanese Circulation Journal

Volumn 60, Issue 3, 1996, Pages 166-170

  Shionoiri, Hiroshi ^a,b   Takasaki, Izumi ^a   Hirawa, Nobuhito ^a   Kihara, Minoru ^a   Gotoh, Eiji ^a   Sasaki, Tetsuo ^a   Nakajima, Hiroshi ^a   Ishii, Masao ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Angioedema; Angioneurotic edema; Angiotensin converting enzyme inhibitor; Enalapril

Indexed keywords

ALLOPURINOL; ANTIHYPERTENSIVE AGENT; AROTINOLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; FUROSEMIDE; METHYLDOPA; NIFEDIPINE; POTASSIUM; PRAVASTATIN;

ADULT; ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; COUGHING; ESSENTIAL HYPERTENSION; HUMAN; LONG TERM CARE; MALE;

ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ENALAPRIL; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0029985634     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.60.166     Document Type: Article

References (27)

1. Israili ZH, Hall WD: Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med 1992; 117: 234-242
2. Omae T, Kawano Y, Yoshida K: Side effects and metabolic effects of converting enzyme inhibitors. Clin Exp Hypertens 1987; A9(2-3): 635-642
3. Cameron HA, Higgins TJC: Clinical experience with lisinopril. Observations on safety and tolerability. J Human Hypertens 1989; 3: 177-186
4. Rees RS, Bergman J, Raminez-Alexandar R: Angioedema associated with lisinopril. Am J Emerg Med 1992; 10: 321-322
5. Roberts JR, Wuerz RC: Clinical characteristics of angiotensin-converting enzyme inhibitor-induced angioedema. Ann Emerg Med 1991; 20: 555-558
6. Slater EE, Merrill DD, Guess HA, Roylance PJ, Cooper WD, Inman WW, Ewan PW: Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988; 260: 967-970
7. Warner NJ, Rush JE: Safety profile of angiotensin converting enzyme inhibitors. Drugs 1988; 35 (Suppl 5): 89-97
8. Oike Y, Ogata Y, Higashi D, Matsumura T, Mumata Y: Fatal angioedema associated with enalapril. Intern Med 1993; 32: 308-310
9. Matsumura M, Haruki K, Kajinami K, Takada T: Angioedema likely related to angiotensin converting enzyme inhibitors. Intern Med 1993; 32: 424-426
10. The Joint National Committee: The 5th report on detection, evaluation and treatment of high blood pressure. Arch Intern Med 1993; 153: 154-183
11. WHO/ISH Mild Hypertension Liaison Committee: The 1993 guidelines for the management of mild hypertension. Hypertension 1993; 22: 392-403
12. Shionoiri H, Sesoko S, Yasuda G, Kaneko Y: Treatment to the mild hypertension: Comments to the guidelines for the treatment of the mild hypertension from the WHO/ISH 1983. Nihon-Iji-Shinpo 1983; 3100: 7-11 (in Japanese)
13. Jett GK: Captopril-induced angioedema. Ann Emerg Med 1984; 13: 489-490
14. Orfan N, Patterson R, Dykewicz MS: Severe angioedema related to ACE inhibitors in patients with a history of idiopathic angioedema. JAMA 1990; 264: 1287-1289
15. Wood SM, Mann RD: Angioedema and urticaria associated with angiotensin converting inhibitors. Br Med J 1987; 297: 91-92
16. Bielory L, Lee SS, Holland CL, Jaker M: Long-term ACE inhibitor-induced angioedema. Allergy Proc 1992; 13: 85-87
17. Chin HL, Buchan DA: Severe angioedema after long-term use of an angiotensin-converting enzyme inhibitor. Ann Intern Med 1990; 112: 312-313
18. Finley CJ, Silverman MA, Nunez AE: Angiotensin-converting enzyme inhibitor-induced angioedema: Still unrecognized. Am J Emerg Med 1992; 10: 550-552
19. Gianos ME, Klaustermeyer WB, Kurohara M, Tarnasky P, Gordon E: Enalapril induced angioedema. Am J Emerg Med 1990; 8: 124-126
20. Singer DRJ, MacGregor GA: Angioneurotic oedema associated with 2 angiotensin converting enzyme inhibitors. Br Med J 1986; 293: 1243
21. Anderson MW, de Shazo RD: Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: The effect of an ACE inhibitor on cutaneous responses to bradykinin, codein, and histaminc. J Allergy Clin Immunol 1990; 85: 856-858
22. Johnston CI, McGrath BP, Miller JA: Long-term effect of captopril on blood pressure and hormones levels in essential hypertension. Lancet 1979; 2: 493-495
23. Shionoiri H, Gotoh E, Miyazaki N, Yasuda G, Takagi N, Uneda S. Kaneko Y: Serum concentration and effects of a single dose of enalapril maleate in patients with essential hypertension. Jpn Circ J 1985; 49: 46-51
24. Ferner RE, Wilson D, Paterson JR, Wilkinson R, Rawlins MD: The effects of intradermal bradykinin are potentiated by angiolensin converting enzyme inhibitors in hypertensive patients. Br J Clin Pharmac 1989; 27: 337-342
25. Mathews KP, Pan PM, Gardner NJ, Hugh TE: Familial carboxypeptidase N deficiency. Ann Intern Med 198S0; 93: 443-445
26. Agostoni A, Cicardi M: Contraindications to the use of ACE inhibitors in patients with C1 esterase inhibitor deficiency. Am J Med 1991; 90: 278
27. Lee SS, Holland CL, Jaker M, Bielory L: Angiotensin converting enzyme (ACE) inhibitors angioedema. J Allergy Clin Immunol 1991; 87 (Suppl 2): 228